Methylation-dependent T cell immunity to Mycobacterium tuberculosis heparin-binding hemagglutinin

[1]  A. Hovav,et al.  The Mycobacterium tuberculosis Recombinant 27-Kilodalton Lipoprotein Induces a Strong Th1-Type Immune Response Deleterious to Protection , 2003, Infection and Immunity.

[2]  C. Locht,et al.  Mycobacterial heparin-binding hemagglutinin and laminin-binding protein share antigenic methyllysines that confer resistance to proteolysis , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[3]  C. Locht,et al.  Differential T and B cell responses against Mycobacterium tuberculosis heparin-binding hemagglutinin adhesin in infected healthy individuals and patients with tuberculosis. , 2002, The Journal of infectious diseases.

[4]  M. Brennan,et al.  Comparative Immune Response to PE and PE_PGRS Antigens of Mycobacterium tuberculosis , 2001, Infection and Immunity.

[5]  C. Locht,et al.  The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination , 2001, Nature.

[6]  J. Flynn,et al.  Induction of M3-Restricted Cytotoxic T Lymphocyte Responses by N-Formylated Peptides Derived from Mycobacterium tuberculosis , 2001, The Journal of experimental medicine.

[7]  B. Barrell,et al.  Massive gene decay in the leprosy bacillus , 2001, Nature.

[8]  C. Locht,et al.  Mycobacterium smegmatis laminin‐binding glycoprotein shares epitopes with Mycobacterium tuberculosis heparin‐binding haemagglutinin , 2001, Molecular microbiology.

[9]  B. Levine,et al.  Efficient priming of protein antigen-specific human CD4(+) T cells by monocyte-derived dendritic cells. , 2000, Blood.

[10]  C. Locht,et al.  Characterization of the Heparin-binding Site of the Mycobacterial Heparin-binding Hemagglutinin Adhesin* , 2000, The Journal of Biological Chemistry.

[11]  B. Kumar,et al.  Interaction of Mycobacterium avium complex with human respiratory epithelial cells. , 2000, The Journal of infectious diseases.

[12]  P. Andersen,et al.  ESAT-6 Subunit Vaccination againstMycobacterium tuberculosis , 2000, Infection and Immunity.

[13]  M. Brennan,et al.  Functional Domains Present in the Mycobacterial Hemagglutinin, HBHA , 1999, Journal of bacteriology.

[14]  G. Delogu,et al.  Immunogenicity of DNA Vaccines Expressing Tuberculosis Proteins Fused to Tissue Plasminogen Activator Signal Sequences , 1999, Infection and Immunity.

[15]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[16]  C. Locht,et al.  Molecular characterization of the mycobacterial heparin-binding hemagglutinin, a mycobacterial adhesin. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[17]  F. Deist,et al.  Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency. , 1998, Science.

[18]  C. Locht,et al.  Identification of a heparin-binding hemagglutinin present in mycobacteria , 1996, The Journal of experimental medicine.

[19]  Donna L. Montgomery,et al.  Immunogenicity and protective efficacy of a tuberculosis DNA vaccine , 1996, Nature Medicine.

[20]  M. Colston,et al.  Vaccination against tuberculosis by DNA injection , 1996, Nature Medicine.

[21]  M. Bevan,et al.  Identification of an H2-M3-restricted Listeria epitope: implications for antigen presentation by M3. , 1996, Immunity.

[22]  W. Chan,et al.  Fmoc Solid Phase Peptide Synthesis: A Practical Approach (Practical Approach Series) , 2019 .

[23]  D. Young,et al.  Prospects for new interventions in the treatment and prevention of mycobacterial disease. , 1995, Annual review of microbiology.